Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View
Abstract
:Simple Summary
Abstract
1. Introduction
2. Diagnosis
2.1. Endoscopy
2.2. Histopathological Features
2.3. Search for H. pylori
2.4. The Case of H. pylori-Negative Lymphomas
3. Pre-Treatment Work-Up and Staging
3.1. Pre-Treatment Diagnostic Measures
3.2. Staging Systems or Classifications
4. Treatments
4.1. H. pylori Eradication
4.2. Surveillance after Effective H. pylori Eradication
4.3. Other Treatments after H. pylori Eradication
5. GML, Gastric Precancerous Lesions and Gastric Adenocarcinoma
6. Surveillance after Complete Remission of Lymphoma
7. Prognosis
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Wotherspoon, A.C.; Doglioni, C.; Diss, T.C.; Pan, L.; Moschini, A.; de Boni, M.; Isaacson, P.G. Regression of primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993, 342, 575–577. [Google Scholar] [CrossRef]
- Isaacson, P.G. Update on MALT lymphomas. Best Pract. Res. Clin. Haematol. 2005, 18, 57–68. [Google Scholar] [CrossRef]
- Severson, R.K.; Davis, S. Increasing incidence of primary gastric lymphoma. Cancer 1990, 66, 1283–1287. [Google Scholar] [CrossRef]
- Luminari, S.; Cesaretti, M.; Marcheselli, L.; Rashid, I.; Madrigali, S.; Maiorana, A.; Federico, M. Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions: Results from a population-based study on extranodal marginal zone lymphomas. Ann. Oncol. 2010, 21, 855–859. [Google Scholar] [CrossRef]
- Borka Balas, R.; Meliț, L.E.; Mărginean, C.O. Worldwide Prevalence and Risk Factors of Helicobacter pylori Infection in Children. Children 2022, 9, 1359. [Google Scholar] [CrossRef]
- Ishioka, M.; Hirasawa, T.; Mishima, Y. Latest trends in the incidence of Helicobacter pylori-uninfected gastric mucosa-associated lymphoid tissue lymphoma at the Cancer Institute Hospital, Japan. Int. J. Hematol. 2021, 113, 770–771. [Google Scholar] [CrossRef]
- Asano, N.; Iijima, K.; Koike, T.; Imatani, A.; Shimosegawa, T. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review. World J. Gastroenterol. 2015, 21, 8014–8020. [Google Scholar] [CrossRef] [PubMed]
- Ruskoné-Fourmestraux, A.; Fischbach, W.; Aleman, B.M.; Boot, H.; Du, M.Q.; Megraud, F.; Montalban, C.; Raderer, M.; Savio, A.; Wotherspoon, A.; et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 2011, 60, 747–758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dreyling, M.; Thieblemont, C.; Gallamini, A.; Arcaini, L.; Campo, E.; Hermine, O.; Kluin-Nelemans, J.C.; Ladetto, M.; Le Gouill, S.; Iannitto, E.; et al. ESMO Consensus conferences: Guidelines on malignant lymphoma. part 2: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann. Oncol. 2013, 24, 857–877. [Google Scholar] [CrossRef] [PubMed]
- Zucca, E.; Arcaini, L.; Buske, C.; Johnson, P.W.; Ponzoni, M.; Raderer, M.; Ricardi, U.; Salar, A.; Stamatopoulos, K.; Thieblemont, C.; et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2020, 31, 17–29. [Google Scholar] [CrossRef] [Green Version]
- Matysiak-Budnik, T.; Fabiani, B.; Hennequin, C.; Thieblemont, C.; Malamut, G.; Cadiot, G.; Bouché, O.; Ruskoné-Fourmestraux, A. Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH). Dig. Liver Dis. 2018, 50, 124–131. [Google Scholar] [CrossRef]
- Ruskoné-Fourmestraux, A.; Matysiak-Budnik, T.; Fabiani, B.; Quero, L.; Malamut, G.; Thieblemont, C.; Bouché, O. Lymphomes gastro-intestinaux. Thésaurus Natl. Cancérologie Dig. 2022. Available online: http://www.tncd.org (accessed on 1 July 2022).
- De Jong, D.; Aleman, B.M.; Taal, B.G.; Boot, H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey. Ann. Oncol. 1999, 10, 275–280. [Google Scholar] [CrossRef] [PubMed]
- Taal, B.G.; den Hartog Jager, F.C.; Burgers, J.M.; van Heerde, P.; Tio, T.L. Primary non-Hodgkin’s lymphoma of the stomach: Changing aspects and therapeutic choices. Eur. J. Cancer Clin. Oncol. 1989, 25, 439–450. [Google Scholar] [CrossRef] [PubMed]
- Fischbach, W.; Dragosics, B.; Kolve-Goebeler, M.E.; Ohmann, C.; Greiner, A.; Yang, Q.; Böhm, S.; Verreet, P.; Horstmann, O.; Busch, M.; et al. Primary gastric B-cell lymphoma: Results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology 2000, 119, 1191–1202. [Google Scholar] [CrossRef]
- Fischbach, W. MALT lymphoma: Forget surgery? Dig. Dis. 2013, 31, 38–42. [Google Scholar] [CrossRef]
- Ruskoné-Fourmestraux, A.; Matysiak-Budnik, T.; Fabiani, B.; Cervera, P.; Brixi, H.; Le Malicot, K.; Nion-Larmurier, I.; Fléjou, J.F.; Hennequin, C.; Quéro, L.; et al. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up. Radiother. Oncol. 2015, 117, 178–182. [Google Scholar] [CrossRef]
- Nam, T.K.; Ahn, J.S.; Choi, Y.D.; Jeong, J.U.; Kim, Y.H.; Yoon, M.S.; Song, J.Y.; Ahn, S.J.; Chung, W.K. The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Res. Treat. 2014, 46, 33–40. [Google Scholar] [CrossRef] [PubMed]
- Schmelz, R.; Miehlke, S.; Thiede, C.; Brueckner, S.; Dawel, M.; Kuhn, M.; Ruskoné-Formestraux, A.; Stolte, M.; Jentsch, C.; Hampe, J.; et al. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: A prospective randomized trial. J. Gastroenterol. 2019, 54, 388–395. [Google Scholar] [CrossRef]
- Salar, A.; Domingo-Domenech, E.; Panizo, C.; Nicolás, C.; Bargay, J.; Muntañola, A.; Canales, M.; Bello, J.L.; Sancho, J.M.; Tomás, J.F.; et al. Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma. Blood 2017, 130, 1772–1774. [Google Scholar] [CrossRef] [Green Version]
- Teckie, S.; Qi, S.; Chelius, M.; Lovie, S.; Hsu, M.; Noy, A.; Portlock, C.; Yahalom, J. Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma. Ann. Oncol. 2017, 28, 1064–1069. [Google Scholar] [CrossRef]
- Fischbach, W.; Goebeler, M.E.; Ruskone-Fourmestraux, A.; Wündisch, T.; Neubauer, A.; Raderer, M.; Savio, A.; EGILS (European Gastro-Intestinal Lymphoma Study) Group. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: Experience from a large international series. Gut 2007, 56, 1685–1687. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dolak, W.; Kiesewetter, B.; Müllauer, L.; Mayerhoefer, M.; Troch, M.; Trauner, M.; Häfner, M.; Raderer, M.; Püspök, A. A pilot study of confocal laser endomicroscopy for diagnosing gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma. Surg. Endosc. 2016, 30, 2879–2885. [Google Scholar] [CrossRef]
- Deng, P.; Min, M.; Ma, C.Y.; Liu, Y. Linked Color Imaging Technology for Diagnosis of Gastric Mucosa-associated Lymphoid Tissue Lymphoma. Chin. Med. J. 2017, 130, 2759–2760. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Cheng, H.H.; Deng, S.; Kuang, D.; Shu, C.; Cao, L.; Liao, G.Q.; Guo, Q.Z.; Zhou, Q. Diagnosis of Superficial Gastric Lesions Together with Six Gastric Lymphoma Cases via Probe-Based Confocal Laser Endomicroscopy: A Retrospective Observational Study. Gastroenterol. Res. Pract. 2018, 2018, 5073182. [Google Scholar] [CrossRef] [PubMed]
- Peng, T.; Deng, L.; Wang, Y.; Wang, R.; Zeng, F.; Xie, M.; Gou, X.; Guo, Y.; Wu, D.; Peng, F.; et al. Establishing an endoscopic diagnostic process system (M-system) for gastric MALT lymphoma of superficial-spreading type. JPN J. Clin. Oncol. 2021, 51, 560–568. [Google Scholar] [CrossRef] [PubMed]
- Matysiak-Budnik, T.; Jamet, P.; Ruskoné-Fourmestraux, A.; de Mascarel, A.; Velten, M.; Maynadié, M.; Woronoff, A.S.; Trétarre, B.; Marrer, E.; Delafosse, P.; et al. Gastric MALT lymphoma in a population-based study in France: Clinical features, treatments and survival. Aliment. Pharmacol. Ther. 2019, 50, 654–663. [Google Scholar] [CrossRef]
- Rossi, D.; Bertoni, F.; Zucca, E. Marginal-Zone Lymphomas. N. Engl. J. Med. 2022, 386, 568–581. [Google Scholar] [CrossRef]
- Kadota, H.; Yuge, R.; Miyamoto, R.; Otani, R.; Takigawa, H.; Hayashi, R.; Urabe, Y.; Oka, S.; Sentani, K.; Oue, N.; et al. Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma. Helicobacter 2022, 27, e12887. [Google Scholar] [CrossRef]
- Hassegawa, R.T.; Ogawa, E.K.M.; Ibrahim, R.E.; Venco, F.E.; Maruta, L.M. Pre-malignant signs of gastric MALT lymphoma. Autops. Case Rep. 2020, 10, e2019130. [Google Scholar] [CrossRef]
- Nonaka, K.; Ishikawa, K.; Arai, S.; Nakao, M.; Shimizu, M.; Sakurai, T.; Nagata, K.; Nishimura, M.; Togawa, O.; Ochiai, Y.; et al. A case of gastric mucosa-associated lymphoid tissue lymphoma in which magnified endoscopy with narrow band imaging was useful in the diagnosis. World J. Gastrointest. Endosc. 2012, 4, 151–156. [Google Scholar] [CrossRef] [PubMed]
- Han, J.; Wang, J.; Xie, H.P. Gastric Mucosa-Associated Lymphoid Tissue Lymphomas Diagnosed by Jumbo Biopsy Using Endoscopic Submucosal Dissection: A Case Report. Front. Med. 2021, 8, 668531. [Google Scholar] [CrossRef]
- Pinto, C.; Cunha, A.L.; Rodrigues, Â.; Dias, R.; Brandão, C.; Dinis-Ribeiro, M. Diagnosis of MALT Lymphoma from Surveillance Endoscopy of a Patient with a CDH1 Gene Germline Mutation. GE Port. J. Gastroenterol. 2021, 29, 51–55. [Google Scholar] [CrossRef]
- Fischbach, W. Gastric mucosa-associated lymphoid tissue lymphoma: A challenge for endoscopy. Gastrointest. Endosc. 2008, 68, 632–634. [Google Scholar] [CrossRef]
- Zullo, A.; Hassan, C.; Andriani, A.; Cristofari, F.; Cardinale, V.; Spinelli, G.P.; Tomao, S.; Morini, S. Primary low-grade and high-grade gastric MALT-lymphoma presentation. J. Clin. Gastroenterol. 2010, 44, 340–344. [Google Scholar] [CrossRef]
- Nonaka, K.; Ishikawa, K.; Shimizu, M.; Sakurai, T.; Nakai, Y.; Nakao, M.; Yoshino, K.; Arai, S.; Kita, H. Education and Imaging. Gastrointestinal: Gastric mucosa-associated lymphoma presented with unique vascular features on magnified endoscopy combined with narrow-band imaging. J. Gastroenterol. Hepatol. 2009, 24, 1697. [Google Scholar] [CrossRef] [PubMed]
- Nonaka, K.; Ohata, K.; Ban, S.; Takita, M.; Minato, Y.; Matsuhashi, N. Confocal laser endomicroscopic and magnifying narrow-band imaging findings of gastric mucosa-associated lymphoid tissue lymphoma. Endoscopy 2015, 47, e641–e642. [Google Scholar] [CrossRef] [PubMed]
- Isomoto, H.; Ishii, H.; Matsushima, K.; Ohnita, K.; Nakayama, T.; Hayashi, T.; Nakao, K. Gastrointestinal: Novel endocytoscopic findings of gastric low-grade mucosa-associated lymphoid tissue lymphoma. J. Gastroenterol. Hepatol. 2012, 27, 1535. [Google Scholar] [CrossRef] [Green Version]
- Isomoto, H.; Matsushima, K.; Hayashi, T.; Imaizumi, Y.; Shiota, J.; Ishii, H.; Minami, H.; Ohnita, K.; Takeshima, F.; Shikuwa, S.; et al. Endocytoscopic findings of lymphomas of the stomach. BMC Gastroenterol. 2013, 13, 174. [Google Scholar] [CrossRef] [Green Version]
- Seya, M.; Dohi, O.; Yamauchi, K.; Fukui, H.; Miyazaki, H.; Yasuda, T.; Inoue, K.; Yoshida, N.; Morinaga, Y.; Itoh, Y. Endoscopic submucosal dissection for protruding Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the stomach: A case report. Clin. J. Gastroenterol. 2022, 15, 881–885. [Google Scholar] [CrossRef]
- Wang, X.Y.; Chen, Y.; Zhang, Q.W.; Tang, Z.R.; Li, X.B. Diagnostic endoscopic submucosal dissection in the diagnosis of biopsy-missed gastric mucosa-associated lymphoid tissue lymphoma. J. Dig. Dis. 2021, 22, 615–618. [Google Scholar] [CrossRef] [PubMed]
- Ruskoné-Fourmestraux, A.; Lavergne, A.; Aegerter, P.H.; Megraud, F.; Palazzo, L.; de Mascarel, A.; Molina, T.; Rambaud, J.L. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001, 48, 297–303. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lehours, P.; Ruskone-Fourmestraux, A.; Lavergne, A.; Cantet, F.; Mégraud, F.; Groupe d’Etude des Lymphomes Digestifs (GELD) for the Fédération Française de Cancérologie Digestive (FFCD). Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am. J. Gastroenterol. 2003, 98, 291–295. [Google Scholar] [CrossRef] [PubMed]
- Swerdlow, S.H.; Campo, E.; Pileri, S.A.; Harris, N.L.; Stein, H.; Siebert, R.; Advani, R.; Ghielmini, M.; Salles, G.A.; Zelenetz, A.D.; et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016, 127, 2375–2390. [Google Scholar] [CrossRef] [Green Version]
- Nakamura, S.; Ponzoni, M. Marginal zone B-cell lymphoma: Lessons from Western and Eastern diagnostic approaches. Pathology 2020, 52, 15–29. [Google Scholar] [CrossRef] [Green Version]
- Copie-Bergman, C.; Wotherspoon, A.C.; Capella, C.; Motta, T.; Pedrinis, E.; Pileri, S.A.; Bertoni, F.; Conconi, A.; Zucca, E.; Ponzoni, M.; et al. Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br. J. Haematol. 2013, 160, 47–52. [Google Scholar] [CrossRef]
- Ayada, Y.; Igawa, T.; Naoi, Y.; Horikawa, K.; Tabata, T.; Tanaka, T.; Yoshino, T. Immunohistochemistry for IRTA1 and MNDA helps differentiate gastric MALT lymphoma from chronic gastritis/reactive lymphocyte hyperplasia. J. Clin. Exp. Hematop. 2022, 62, 195–201. [Google Scholar] [CrossRef]
- Kuo, S.H.; Yeh, K.H.; Wu, M.S.; Lin, C.W.; Wei, M.F.; Liou, J.M.; Wang, H.P.; Chen, L.T.; Cheng, A.L. First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma. Sci. Rep. 2017, 7, 14333. [Google Scholar] [CrossRef] [Green Version]
- Toyoda, K.; Maeshima, A.M.; Nomoto, J.; Suzuki, T.; Yuda, S.; Yamauchi, N.; Taniguchi, H.; Makita, S.; Fukuhara, S.; Munakata, W.; et al. Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: Long-term follow-up results. Ann. Hematol. 2019, 98, 1675–1687. [Google Scholar] [CrossRef]
- Dong, G.; Liu, C.; Ye, H.; Gong, L.; Zheng, J.; Li, M.; Huang, X.; Huang, X.; Huang, Y.; Shi, Y.; et al. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int. J. Hematol. 2008, 88, 516–523. [Google Scholar] [CrossRef]
- Liu, H.; Ye, H.; Dogan, A.; Ranaldi, R.; Hamoudi, R.A.; Bearzi, I.; Isaacson, P.G.; Du, M.Q. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001, 98, 1182–1187. [Google Scholar] [CrossRef] [Green Version]
- Liu, H.; Ruskone-Fourmestraux, A.; Lavergne-Slove, A.; Ye, H.; Molina, T.; Bouhnik, Y.; Hamoudi, R.A.; Diss, T.C.; Dogan, A.; Megraud, F.; et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001, 357, 39–40. [Google Scholar] [CrossRef]
- Liu, H.; Ye, H.; Ruskone-Fourmestraux, A.; De Jong, D.; Pileri, S.; Thiede, C.; Lavergne, A.; Boot, H.; Caletti, G.; Wündisch, T.; et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002, 122, 1286–1294. [Google Scholar] [CrossRef]
- Xie, Y.L.; He, C.Y.; Wei, S.Q.; Guan, W.J.; Jiang, Z. Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta analysis. Chin. Med. J. 2020, 133, 1337–1346. [Google Scholar] [CrossRef]
- Lehours, P. Actual diagnosis of Helicobacter pylori infection. Minerva Gastroenterol. Dietol. 2018, 64, 267–279. [Google Scholar] [CrossRef] [PubMed]
- El-Serag, H.B.; Kao, J.Y.; Kanwal, F.; Gilger, M.; LoVecchio, F.; Moss, S.F.; Crowe, S.E.; Elfant, A.; Haas, T.; Hapke, R.J.; et al. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin. Gastroenterol. Hepatol. 2018, 16, 992–1002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schaberg, K.B.; Evans, M.F.; Wilcox, R.; Lewis, M.R. Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma. Ann. Diagn. Pathol. 2015, 19, 397–402. [Google Scholar] [CrossRef]
- Malfertheiner, P.; Megraud, F.; Rokkas, T.; Gisbert, J.P.; Liou, J.M.; Schulz, C.; Gasbarrini, A.; Hunt, R.H.; Leja, M.; O’Morain, C.; et al. Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut 2022, 327745. [Google Scholar] [CrossRef]
- Kiesewetter, B.; Simonitsch-Klupp, I.; Mayerhoefer, M.E.; Dolak, W.; Lukas, J.; Raderer, M. First Line Systemic Treatment for MALT Lymphoma-Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna. Cancers 2020, 12, 3533. [Google Scholar] [CrossRef] [PubMed]
- Godbole, G.; Mégraud, F.; Bessède, E. Review: Diagnosis of Helicobacter pylori infection. Helicobacter 2020, 25, e12735. [Google Scholar] [CrossRef]
- Du, M.Q.; Atherton, J.C. Molecular subtyping of gastric MALT lymphomas: Implications for prognosis and management. Gut 2006, 55, 886–893. [Google Scholar] [CrossRef] [PubMed]
- Kuo, S.H.; Yeh, K.-H.; Lin, C.-W.; Liou, J.-M.; Wu, M.-S.; Chen, L.-T.; Cheng, A.-L. Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers 2022, 14, 1005. [Google Scholar] [CrossRef] [PubMed]
- Kiesewetter, B.; Copie-Bergman, C.; Levy, M.; Wu, F.; Dupuis, J.; Barau, C.; Arcaini, L.; Paulli, M.; Lucioni, M.; Bonometti, A.; et al. Genetic Characterization and Clinical Features of Helicobacter pylori Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers 2021, 13, 2993. [Google Scholar] [CrossRef]
- Steinbach, G.; Ford, R.; Glober, G.; Sample, D.; Hagemeister, F.B.; Lynch, P.M.; McLaughlin, P.W.; Rodriguez, M.A.; Romaguera, J.E.; Sarris, A.H.; et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann. Intern. Med. 1999, 131, 88–95. [Google Scholar] [CrossRef] [PubMed]
- Jung, K.; Kim, D.H.; Seo, H.I.; Gong, E.J.; Bang, C.S. Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta-analysis. Helicobacter 2021, 26, e12774. [Google Scholar] [CrossRef]
- Troch, M.; Woehrer, S.; Streubel, B.; Weissel, M.; Hoffmann, M.; Müllauer, L.; Chott, A.; Raderer, M. Chronic autoimmune thyroiditis (Hashimoto’s thyroiditis) in patients with MALT lymphoma. Ann. Oncol. 2008, 19, 1336–1339. [Google Scholar] [CrossRef]
- Morgner, A.; Lehn, N.; Andersen, L.P.; Thiede, C.; Bennedsen, M. Helicobacter heilmannii–Associated Primary Gastric Low-Grade MALT Lymphoma: Complete Remission After Curing the Infection. Gastroenterology 2000, 118, 821–828. [Google Scholar] [CrossRef]
- Okamura, T.; Iwaya, Y.; Yokosawa, S.; Suga, T.; Arakura, N.; Matsumoto, T.; Ogiwara, N.; Higuchi, K.; Ota, H.; Tanaka, E. A case of Helicobacter heilmannii-associated primary gastric mucosa-associated lymphoid tissue lymphoma achieving complete remission after eradication. Clin. J. Gastroenterol. 2013, 6, 38–45. [Google Scholar] [CrossRef]
- Takigawa, H.; Masaki, S.; Naito, T.; Yuge, R.; Urabe, Y.; Tanaka, S.; Sentani, K.; Matsuo, T.; Matsuo, K.; Chayama, K.; et al. Helicobacter suis infection is associated with nodular gastritis-like appearance of gastric mucosa-associated lymphoid tissue lymphoma. Cancer Med. 2019, 8, 4370–4379. [Google Scholar] [CrossRef] [Green Version]
- Naito, T.; Yuge, R.; Tanaka, S.; Otani, R.; Kadota, H.; Takigawa, H.; Tamura, T.; Sentani, K.; Yasui, W.; Kitadai, Y.; et al. Gastric mucosa-associated lymphoid tissue lymphoma in conjunction with multiple lymphomatous polyposis in the context of Helicobacter pylori and Helicobacter suis superinfection. Clin. J. Gastroenterol. 2021, 14, 478–483. [Google Scholar] [CrossRef]
- Takigawa, H.; Yuge, R.; Masaki, S.; Otani, R.; Kadota, H.; Naito, T.; Hayashi, R.; Urabe, Y.; Oka, S.; Tanaka, S.; et al. Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapy. Gastric Cancer 2021, 24, 937–945. [Google Scholar] [CrossRef]
- Tanaka, T.; Matsuno, Y.; Torisu, T.; Shibata, H.; Hirano, A.; Umeno, J.; Kawasaki, K.; Fujioka, S.; Fuyuno, Y.; Moriyama, T.; et al. Gastric microbiota in patients with Helicobacter pylori-negative gastric MALT lymphoma. Medicine 2021, 100, e27287. [Google Scholar] [CrossRef]
- Floch, P.; Mégraud, F.; Lehours, P. Helicobacter pylori Strains and Gastric MALT Lymphoma. Toxins 2017, 9, 132. [Google Scholar] [CrossRef]
- Raderer, M.; Kiesewetter, B. What you always wanted to know about gastric MALT-lymphoma: A focus on recent developments. Ther. Adv. Med. Oncol. 2021, 13, 17588359211033825. [Google Scholar] [CrossRef]
- Cheson, B.D.; Fisher, R.I.; Barrington, S.F.; Cavalli, F.; Schwartz, L.H.; Zucca, E.; Lister, T.A.; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J. Clin. Oncol. 2014, 32, 3059–3068. [Google Scholar] [CrossRef] [PubMed]
- Cohen, D.; Perry, C.; Hazut-Krauthammer, S.; Kesler, M.; Herishanu, Y.; Luttwak, E.; Even-Sapir, E.; Avivi, I. Is There a Role for [18F]FDG PET-CT in Staging MALT Lymphoma? Cancers 2022, 14, 750. [Google Scholar] [CrossRef]
- Albano, D.; Durmo, R.; Treglia, G.; Giubbini, R.; Bertagna, F. 18F-FDG PET/CT or PET Role in MALT Lymphoma: An Open Issue not Yet Solved-A Critical Review. Clin. Lymphoma Myeloma Leuk. 2020, 20, 137–146. [Google Scholar] [CrossRef] [PubMed]
- Song, K.H.; Yun, M.; Kim, J.H.; Yang, W.I.; Kang, D.R.; Chung, J.B.; Lee, Y.C. Role of F-FDG PET Scans in Patients with Helicobacter pylori-Infected Gastric Low-Grade MALT Lymphoma. Gut Liver 2011, 5, 308–314. [Google Scholar] [CrossRef] [Green Version]
- Treglia, G.; Zucca, E.; Sadeghi, R.; Cavalli, F.; Giovanella, L.; Ceriani, L. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: A meta-analysis. Hematol. Oncol. 2015, 33, 113–124. [Google Scholar] [CrossRef]
- Raderer, M.; Kiesewetter, B.; Mayerhoefer, M.E. Positron emission tomography/magnetic resonance imaging (PET/MRI) vs. gastroscopy: Can it improve detection of extranodal marginal zone lymphomas of the stomach following H. pylori treatment? Expert. Rev. Hematol. 2022, 15, 565–571. [Google Scholar] [CrossRef]
- Radaszkiewicz, T.; Dragosics, B.; Bauer, P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis. Gastroenterology 1992, 102, 1628–1638. [Google Scholar] [CrossRef] [PubMed]
- Rohatiner, A.; d’Amore, F.; Coiffier, B.; Crowther, D.; Gospodarowicz, M.; Isaacson, P.; Lister, T.A.; Norton, A.; Salem, P.; Shipp, M. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann. Oncol. 1994, 5, 397–400. [Google Scholar] [CrossRef] [PubMed]
- Ruskoné-Fourmestraux, A.; Dragosics, B.; Morgner, A.; Wotherspoon, A.; De Jong, D. Paris staging system for primary gastrointestinal lymphomas. Gut 2003, 52, 912–913. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moleiro, J.; Ferreira, S.; Lage, P.; Dias Pereira, A. Gastric malt lymphoma: Analysis of a series of consecutive patients over 20 years. United Eur. Gastroenterol. J. 2016, 4, 395–402. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.S.; Park, J.C.; Lee, J.Y.; Ahn, J.Y.; Kang, S.H.; Yang, H.J.; Kim, S.J.; Joo, M.K.; Park, J.M. Long-Term Clinical Outcomes of Gastric MALT Lymphoma: A Nationwide Multicenter Study in Korea. Front. Oncol. 2021, 11, 681689. [Google Scholar] [CrossRef]
- NCCN Guidelines Version 5. 2023. Available online: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480 (accessed on 23 July 2023).
- Ferreri, A.J.M.; Sassone, M.; Kiesewetter, B.; Govi, S.; Scarfò, L.; Donadoni, G.; Raderer, M. High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): The HD-K phase II trial. Ann. Oncol. 2015, 26, 1760–1765. [Google Scholar] [CrossRef]
- Ferreri, A.J.M.; Cecchetti, C.; Kiesewetter, B.; Sassone, M.; Calimeri, T.; Perrone, S.; Ponzoni, M.; Raderer, M. Clarithromycin as a “repurposing drug” against MALT lymphoma. Br. J. Haematol. 2018, 182, 913–915. [Google Scholar] [CrossRef] [Green Version]
- Nakamura, S.; Sugiyama, T.; Matsumoto, T.; Iijima, K.; Ono, S.; Tajika, M.; Tari, A.; Kitadai, Y.; Matsumoto, H.; Nagaya, T.; et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: A multicentre cohort follow-up study of 420 patients in Japan. Gut 2012, 61, 507–513. [Google Scholar] [CrossRef]
- Akamatsu, T.; Mochizuki, T.; Okiyama, Y.; Matsumoto, A.; Miyabayashi, H.; Ota, H. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter 2006, 11, 86–95. [Google Scholar] [CrossRef]
- Janssen, J. The impact of EUS in primary gastric lymphoma. Best Pract. Res. Clin. Gastroenterol. 2009, 23, 671–678. [Google Scholar] [CrossRef]
- Stathis, A.; Chini, C.; Bertoni, F.; Proserpio, I.; Capella, C.; Mazzucchelli, L.; Pedrinis, E.; Cavalli, F.; Pinotti, G.; Zucca, E. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann. Oncol. 2009, 20, 1086–1093. [Google Scholar] [CrossRef]
- Zullo, A.; Hassan, C.; Ridola, L.; De Francesco, V.; Rossi, L.; Tomao, S.; Vaira, D.; Genta, R.M. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: A systematic review. J. Clin. Gastroenterol. 2013, 47, 824–827. [Google Scholar] [CrossRef] [PubMed]
- Raderer, M.; Wöhrer, S.; Kiesewetter, B.; Dolak, W.; Lagler, H.; Wotherspoon, A.; Muellauer, L.; Chott, A. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: A single center experience with prolonged follow-up. Ann. Hematol. 2015, 94, 969–973. [Google Scholar] [CrossRef]
- Nakamura, S.; Matsumoto, T.; Ye, H.; Nakamura, S.; Suekane, H.; Matsumoto, H.; Yao, T.; Tsuneyoshi, M.; Du, M.Q.; Iida, M. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 2006, 107, 2770–2778. [Google Scholar] [CrossRef]
- Saito, Y.; Suzuki, H.; Tsugawa, H.; Imaeda, H.; Matsuzaki, J.; Hirata, K.; Hosoe, N.; Nakamura, M.; Mukai, M.; Saito, H.; et al. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS ONE 2012, 7, e47396. [Google Scholar] [CrossRef] [Green Version]
- Nakamura, S.; Ye, H.; Bacon, C.M.; Goatly, A.; Liu, H.; Banham, A.H.; Ventura, R.; Matsumoto, T.; Iida, M.; Ohji, Y.; et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: A comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007, 56, 1358–1363. [Google Scholar] [CrossRef] [Green Version]
- Wündisch, T.; Thiede, C.; Morgner, A.; Dempfle, A.; Günther, A.; Liu, H.; Ye, H.; Du, M.Q.; Kim, T.D.; Bayerdörffer, E.; et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J. Clin. Oncol. 2005, 23, 8018–8024. [Google Scholar] [CrossRef] [Green Version]
- De Mascarel, A.; Ruskone-Fourmestraux, A.; Lavergne-Slove, A.; Megraud, F.; Dubus, P.; Merlio, J.P. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch 2005, 446, 219–224. [Google Scholar] [CrossRef]
- Matysiak-Budnik, T. CHU de Nantes, Nantes, France. 2019; unpublished work. [Google Scholar]
- Choi, Y.J.; Kim, N.; Paik, J.H.; Kim, J.M.; Lee, S.H.; Park, Y.S.; Hwang, J.H.; Kim, J.W.; Jeong, S.H.; Lee, D.H.; et al. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome. Helicobacter 2013, 18, 197–205. [Google Scholar] [CrossRef]
- Wündisch, T.; Dieckhoff, P.; Greene, B.; Thiede, C.; Wilhelm, C.; Stolte, M.; Neubauer, A. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 2012, 143, 936–942. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yahalom, J.; Xu, A.J.; Noy, A.; Lobaugh, S.; Chelius, M.; Chau, K.; Portlock, C.; Hajj, C.; Imber, B.S.; Straus, D.J.; et al. Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients. Blood Adv. 2021, 5, 1830–1836. [Google Scholar] [CrossRef]
- Nam, H.; Lim, D.H.; Kim, J.J.; Lee, J.H.; Min, B.H.; Lee, H. Long-Term Clinical Outcome and Predictive Factors for Relapse after Radiation Therapy in 145 Patients with Stage I Gastric B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type. Cancers 2021, 13, 169. [Google Scholar] [CrossRef] [PubMed]
- Ohkubo, Y.; Saito, Y.; Ushijima, H.; Onishi, M.; Kazumoto, T.; Saitoh, J.I.; Kubota, N.; Kobayashi, H.; Maseki, N.; Nishimura, Y.; et al. Radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma: Long-term outcomes over 10 years. J. Radiat. Res. 2017, 58, 537–542. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ghorbal, L.; Hdiji, A.; Ben Salah, H.; Elloumi, F.; Frikha, M.; Elloumi, M.; Daoud, J. Place de la radiothérapie pour les lymphomes du mucosa-associated lymphoid tissue gastriques: Résultats d’une étude rétrospective [Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma]. Cancer Radiother. 2018, 22, 763–766. [Google Scholar] [CrossRef]
- Wirth, A.; Gospodarowicz, M.; Aleman, B.M.; Bressel, M.; Ng, A.; Chao, M.; Hoppe, R.T.; Thieblemont, C.; Tsang, R.; Moser, L.; et al. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: A retrospective, multi-centre, International Extranodal Lymphoma Study Group study. Ann. Oncol. 2013, 24, 1344–1351. [Google Scholar] [CrossRef]
- Pinnix, C.C.; Gunther, J.R.; Milgrom, S.A.; Cruz Chamorro, R.J.; Medeiros, L.J.; Khoury, J.D.; Amini, B.; Neelapu, S.; Lee, H.J.; Westin, J.; et al. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 2019, 104, 447–455. [Google Scholar] [CrossRef] [PubMed]
- Smith, C.D.; Gupta, S.; Sinn Chin, Y.; Thompson, S.R. Long term outcomes of gastric mucosa-associated lymphoid tissue lymphoma treated with radiotherapy: A multi-center retrospective cohort study. Hematol. Oncol. 2023, 41, 71–77. [Google Scholar] [CrossRef]
- Available online: https://classic.clinicaltrials.gov/ct2/show/study/NCT04097067 (accessed on 23 July 2023).
- Reinartz, G.; Pyra, R.P.; Lenz, G.; Liersch, R.; Stüben, G.; Micke, O.; Willborn, K.; Hess, C.F.; Probst, A.; Fietkau, R.; et al. Favorable radiation field decrease in gastric marginal zone lymphoma: Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL). Strahlenther. Onkol. 2019, 195, 544–557. [Google Scholar] [CrossRef]
- Lévy, M.; Copie-Bergman, C.; Molinier-Frenkel, V.; Riou, A.; Haioun, C.; Gaulard, P.; Delfau-Larue, M.H.; Sobhani, I.; Leroy, K.; Delchier, J.C. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: Clinical, histological, and molecular follow-up. Leuk. Lymphoma 2010, 51, 284–290. [Google Scholar] [CrossRef]
- Zucca, E.; Conconi, A.; Laszlo, D.; López-Guillermo, A.; Bouabdallah, R.; Coiffier, B.; Sebban, C.; Jardin, F.; Vitolo, U.; Morschhauser, F.; et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J. Clin. Oncol. 2013, 31, 565–572. [Google Scholar] [CrossRef]
- Amiot, A.; Jooste, V.; Gagniere, C.; Lévy, M.; Copie-Bergman, C.; Dupuis, J.; Le Baleur, Y.; Belhadj, K.; Sobhani, I.; Haioun, C.; et al. Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma. Leuk. Lymphoma 2017, 58, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Amiot, A.; Lévy, M.; Copie-Bergman, C.; Dupuis, J.; Szablewski, V.; Le Baleur, Y.; Baia, M.; Belhadj, K.; Sobhani, I.; Leroy, K.; et al. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: A monocentric non-randomised observational study. Aliment. Pharmacol. Ther. 2014, 39, 619–628. [Google Scholar] [CrossRef]
- Sacchi, S.; Marcheselli, L.; Bari, A.; Marcheselli, R.; Pozzi, S.; Luminari, S.; Lombardo, M.; Buda, G.; Lazzaro, A.; Gobbi, P.G.; et al. Secondary malignancies after treatment for indolent non-Hodgkin’s lymphoma: A 16-year follow-up study. Haematologica 2008, 93, 98–404. [Google Scholar] [CrossRef] [Green Version]
- Tahara, T.; Horiguchi, N.; Terada, T.; Yoshida, D.; Okubo, M.; Funasaka, K.; Nakagawa, Y.; Shibata, T.; Ohmiya, N. H. pylori negative gastric MALT lymphoma with API2-MALT1 translocation treated by endoscopic submucosal dissection: A case report. Medicine 2021, 100, e24371. [Google Scholar] [CrossRef] [PubMed]
- Li, Y.; Wang, Z.; Zhang, X.; Yang, J. Does endoscopic submucosal dissection have its place in the treatment of patients with gastric mucosa associated lymphoid tissue lymphoma localized disease after eradication? Acta Gastroenterol. Belg. 2022, 85, 410–411. [Google Scholar] [CrossRef]
- Choi, J. Successful Endoscopic Resection of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Unresponsive to Helicobacter pylori Eradication Therapy. Clin. Endosc. 2022, 55, 136–140. [Google Scholar] [CrossRef]
- Capelle, L.G.; de Vries, A.C.; Looman, C.W.; Casparie, M.K.; Boot, H.; Meijer, G.A.; Kuipers, E.J. Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur. J. Cancer 2008, 44, 2470–2476. [Google Scholar] [CrossRef] [PubMed]
- Palmela, C.; Fonseca, C.; Faria, R.; Baptista, R.B.; Ribeiro, S.; Ferreira, A.O. Increased risk for metachronous gastric adenocarcinoma following gastric MALT lymphoma-A US population-based study. United Eur. Gastroenterol. J. 2017, 5, 473–478. [Google Scholar] [CrossRef] [Green Version]
- Ojima, T.; Tabata, H.; Yamaue, H. Laparoscopic distal gastrectomy for synchronous adenocarcinoma, diffuse large B cell lymphoma and gastrointestinal stromal tumor in the stomach: A case report. Surg. Case Rep. 2022, 8, 89. [Google Scholar] [CrossRef]
- Suwa, T.; Uotani, T.; Inui, W.; Ando, T.; Tashiro, K.; Kasahara, M. A case of signet ring cell carcinoma and mucosa-associated lymphoid tissue lymphoma of the stomach diagnosed simultaneously via magnifying endoscopy with narrow-band imaging. Clin. J. Gastroenterol. 2021, 14, 453–459. [Google Scholar] [CrossRef]
- Choi, K.W.; Joo, M.; Kim, H.S.; Lee, W.Y. Synchronous triple occurrence of MALT lymphoma, schwannoma, and adenocarcinoma of the stomach. World J. Gastroenterol. 2017, 23, 4127–4131. [Google Scholar] [CrossRef] [PubMed]
- Lu, S.N.; Huang, C.; Li, L.L.; Di, L.J.; Yao, J.; Tuo, B.G.; Xie, R. Synchronous early gastric and intestinal mucosa-associated lymphoid tissue lymphoma in a Helicobacter pylori-negative patient: A case report. World J. Clin. Cases 2022, 10, 12447–12454. [Google Scholar] [CrossRef] [PubMed]
- Cammarota, G.; Larocca, L.M.; D’Ugo, D.; Persiani, R.; Cianci, R.; Nocente, R.; Picciocchi, A.; Gasbarrini, G. Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? Hepatogastroenterology 2001, 48, 104–106. [Google Scholar]
- Capitani, N.; Codolo, G.; Vallese, F.; Minervini, G.; Grassi, A.; Cianchi, F.; Troilo, A.; Fischer, W.; Zanotti, G.; Baldari, C.T.; et al. The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling. Cell. Microbiol. 2019, 21, e13006. [Google Scholar] [CrossRef]
- Della Bella, C.; Soluri, M.F.; Puccio, S.; Benagiano, M.; Grassi, A.; Bitetti, J.; Cianchi, F.; Sblattero, D.; Peano, C.; D’Elios, M.M. The Helicobacter pylori CagY Protein Drives Gastric Th1 and Th17 Inflammation and B Cell Proliferation in Gastric MALT Lymphoma. Int. J. Mol. Sci. 2021, 22, 9459. [Google Scholar] [CrossRef] [PubMed]
- Rentien, A.L.; Lévy, M.; Copie-Bergman, C.; Gagniere, C.; Dupuis, J.; Le Baleur, Y.; Belhadj, K.; Sobhani, I.; Haioun, C.; Delchier, J.C.; et al. Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma. Dig. Liver Dis. 2018, 50, 181–188. [Google Scholar] [CrossRef]
- Capelle, L.G.; den Hoed, C.M.; de Vries, A.C.; Biermann, K.; Casparie, M.K.; Meijer, G.A.; Kuipers, E.J. Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: A case-control study. Eur. J. Gastroenterol. Hepatol. 2012, 24, 42–47. [Google Scholar] [CrossRef]
- Chapelle, N.; Péron, M.; Mosnier, J.F.; Quénéhervé, L.; Coron, E.; Bourget, A.; Cauchin, E.; Touchefeu, Y.; Matysiak-Budnik, T. Prevalence, Characteristics and Endoscopic Management of Gastric Premalignant Lesions in France. Dig. Dis. 2020, 38, 286–292. [Google Scholar] [CrossRef]
- Rugge, M.; Meggio, A.; Pravadelli, C.; Barbareschi, M.; Fassan, M.; Gentilini, M.; Zorzi, M.; Pretis, G.; Graham, D.; Genta, R.M. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: A 5-year prospective study of 1755 patients. Gut 2019, 68, 11–17. [Google Scholar] [CrossRef]
- Zullo, A.; Rago, A.; Felici, S.; Licci, S.; Ridola, L.; Caravita di Toritto, T. Onset and Progression of Precancerous Lesions on Gastric Mucosa of Patients Treated for Gastric Lymphoma. J. Gastrointestin. Liver Dis. 2020, 29, 27–31. [Google Scholar] [CrossRef]
- Chapelle, N.; Péron, M.; Quénéhervé, L.; Bourget, A.; Leroy, M.; Touchefeu, Y.; Cauchin, E.; Coron, E.; Mosnier, J.F.; Matysiak-Budnik, T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin. Transl. Gastroenterol. 2020, 11, e00237. [Google Scholar] [CrossRef]
- Den Hollander, W.J.; Holster, I.L.; den Hoed, C.M.; Capelle, L.G.; Tang, T.J.; Anten, M.P.; Prytz-Berset, I.; Witteman, E.M.; Ter Borg, F.; Hartog, G.D.; et al. Surveillance of premalignant gastric lesions: A multicentre prospective cohort study from low incidence regions. Gut 2019, 68, 585–593. [Google Scholar] [CrossRef]
- Lamarque, D.; Levy, M.; Chaumette, M.T.; Roudot-Thoraval, F.; Cavicchi, M.; Auroux, J.; Courillon-Mallet, A.; Haioun, C.; Delchier, J.C. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma. Am. J. Gastroenterol. 2006, 101, 1886–1893. [Google Scholar] [CrossRef]
- Copie-Bergman, C.; Locher, C.; Levy, M.; Chaumette, M.T.; Haioun, C.; Delfau-Larue, M.H.; Leroy, K.; Gaulard, P.; Delchier, J.C. Metachronous gastric MALT lymphoma and early gastric cancer: Is residual lymphoma a risk factor for the development of gastric carcinoma? Ann. Oncol. 2005, 16, 1232–1236. [Google Scholar] [CrossRef]
- Pimentel-Nunes, P.; Libânio, D.; Marcos-Pinto, R.; Areia, M.; Leja, M.; Esposito, G.; Garrido, M.; Kikuste, I.; Megraud, F.; Matysiak-Budnik, T.; et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019, 51, 365–388. [Google Scholar] [CrossRef] [Green Version]
- Banks, M.; Graham, D.; Jansen, M.; Gotoda, T.; Coda, S.; di Pietro, M.; Uedo, N.; Bhandari, P.; Pritchard, D.M.; Kuipers, E.J.; et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019, 68, 1545–1575. [Google Scholar] [CrossRef] [Green Version]
- Pimentel-Nunes, P.; Libânio, D.; Bastiaansen, B.A.J.; Bhandari, P.; Bisschops, R.; Bourke, M.J.; Esposito, G.; Lemmers, A.; Maselli, R.; Messmann, H.; et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2022. Endoscopy 2022, 54, 591–622. [Google Scholar] [CrossRef]
- Shah, S.C.; Piazuelo, M.B.; Kuipers, E.J.; Li, D. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology 2021, 161, 1325–1332. [Google Scholar] [CrossRef] [PubMed]
- Castro, F.A.; Jansen, L.; Krilaviciute, A.; Katalinic, A.; Pulte, D.; Sirri, E.; Ressing, M.; Holleczek, B.; Luttmann, S.; Brenner, H.; et al. Survival of patients with gastric lymphoma in Germany and in the United States. J. Gastroenterol. Hepatol. 2015, 30, 1485–1491. [Google Scholar] [CrossRef] [PubMed]
- Chen, L.T.; Lin, J.T.; Tai, J.J.; Chen, G.H.; Yeh, H.Z.; Yang, S.S.; Wang, H.P.; Kuo, S.H.; Sheu, B.S.; Jan, C.M. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J. Natl. Cancer Inst. 2005, 97, 1345–1353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kiesewetter, B.; Lamm, W.; Dolak, W.; Lukas, J.; Mayerhoefer, M.E.; Weber, M.; Schiefer, A.I.; Kornauth, C.; Bayer, G.; Simonitsch-Klupp, I.; et al. Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis. Br. J. Haematol. 2019, 186, 448–459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ueda, K.; Terui, Y.; Yokoyama, M.; Sakajiri, S.; Nishimura, N.; Tsuyama, N.; Takeuchi, K.; Hatake, K. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Leuk. Lymphoma 2013, 54, 1928–1933. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Matysiak-Budnik, T.; Priadko, K.; Bossard, C.; Chapelle, N.; Ruskoné-Fourmestraux, A. Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View. Cancers 2023, 15, 3811. https://doi.org/10.3390/cancers15153811
Matysiak-Budnik T, Priadko K, Bossard C, Chapelle N, Ruskoné-Fourmestraux A. Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View. Cancers. 2023; 15(15):3811. https://doi.org/10.3390/cancers15153811
Chicago/Turabian StyleMatysiak-Budnik, Tamara, Kateryna Priadko, Céline Bossard, Nicolas Chapelle, and Agnès Ruskoné-Fourmestraux. 2023. "Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View" Cancers 15, no. 15: 3811. https://doi.org/10.3390/cancers15153811